Kriya Therapeutics Stock
Operator of a gene therapy company focused on designing and developing gene therapies for diseases with underlying biological causes. The company utilizes a vector design platform to enhance its ability to perform de novo construct design, targeted sequence modification, and data analysis, helping physicians reduce immunogenicity and improve tissue specificity.
Founded: 2019
For more Kriya Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Kriya Therapeutics Company Overview
null
Management Team
| Shankar Ramaswamy, MD Co-Founder, Chairman and Chief Executive Officer |
| Curt Herberts, MBS President & Chief Operating Officer |
| Michele Stone, PhD Chief Scientific Officer |
| Fraser Wright, PhD Scientific Co-Founder and Chief Gene Therapy Officer |
| Britt Petty Chief Manufacturing Officer |
| Brian Furmanski, PhD Chief Development Officer |
